The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of novel metastatic prostate cancer cell lines by “organoid” in vitro culture technology.
Ian Vela
No relevant relationships to disclose
Dong Gao
No relevant relationships to disclose
Anuradha Gopalan
No relevant relationships to disclose
Andrea Sboner
No relevant relationships to disclose
Eva Undvall
No relevant relationships to disclose
Jackline Wanjala
No relevant relationships to disclose
Phillip Iaquinta
No relevant relationships to disclose
John Wongvipat
No relevant relationships to disclose
Wouter Karthaus
No relevant relationships to disclose
Hans Clevers
No relevant relationships to disclose
Stephen Barnett Solomon
No relevant relationships to disclose
Himisha Beltran
No relevant relationships to disclose
Myriam Kossai
No relevant relationships to disclose
Juan Miguel Mosquera
No relevant relationships to disclose
Mark A. Rubin
No relevant relationships to disclose
Brett Stewart Carver
No relevant relationships to disclose
Howard I. Scher
No relevant relationships to disclose
Charles L. Sawyers
No relevant relationships to disclose
Yu Chen
No relevant relationships to disclose